Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/2010
06/02/2010CN101249266B Nano liver target direction amphipathic nature block copolymers drug administration system and preparation
06/01/2010US7728188 Methods and compositions for topical wound treatment
06/01/2010US7728010 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
06/01/2010US7727995 Antiherpes drug combinations
06/01/2010US7727994 administering adenosine receptor antagonist; side effect reduction; Parkinson's disease
06/01/2010US7727993 administering adenosine receptor antagonist with dopamine antagonist;; Parkinson's disease; side effect reduction; low dosage of dopamine
06/01/2010US7727992 2-(3-Ethyl-ureido)-6-pyridin-3-yl-3H-benzoimidazole-4-carboxylic acid methyl ester; for treating bacterial infections in mammals; useful in treating or lessening severity of urinary tract infections, pneumonia, prostatitis, skin and soft tissue infections, intra-abdominal infections
06/01/2010US7727977 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes
06/01/2010US7727964 Peptides substituted with a functional group that reacts with an active site residue of the targeted protease, e.g., Cyclohexylglycine BoroAla, and compounds that can hydrolyzed to produce them; improved specificity for regulating glucose metabolism
06/01/2010US7727957 Treatment and delay of outset of Parkinson's disease
06/01/2010US7727735 Detection and treatment of prostate cancer
06/01/2010US7727731 Potent, selective and non toxic c-kit inhibitors
06/01/2010US7727560 Treating cancer, liver, kidney, platelet and hemopoietic disorder or complication
06/01/2010US7727546 Nutrient system for individualized responsive dosing regimens
06/01/2010US7727536 EG-VEGF nucleic acids and polypeptides and methods of use
06/01/2010US7727527 Anti-NGF antibodies for the therapeutic treatments
06/01/2010US7727519 Method for treating hepatitis C virus with omega interferon
06/01/2010US7727518 Method of using IL-29 cysteine mutant to treat hepatitis C and hepatitis B
06/01/2010CA2543640C Oral antidepressant formulation comprising acetylsalicylic acid to accelerate onset of action
06/01/2010CA2509775C Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
06/01/2010CA2448737C Viral polymerase inhibitors
06/01/2010CA2426625C Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
06/01/2010CA2420055C Fibrinogen-lowering agent
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
06/01/2010CA2370666C A tenascin-c isoform as a marker for neoplasias
06/01/2010CA2336879C Sustained-release formulations comprising peptides, polypeptides, proteins or nucleic acids as active ingredients
05/2010
05/28/2010CA2645455A1 A method of medically treating an individual
05/27/2010WO2010059589A1 Anticancer combination comprising docetaxel and an antisense oligonucleotide
05/27/2010WO2010058824A1 Substance for regulating differentiation into mesenchymal cell, and use thereof
05/27/2010WO2010057596A2 New therapy and medicament using integrin ligands for treating cancer
05/27/2010WO2010057295A1 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
05/27/2010US20100131258 Method for identifying protein synthesis inhibitors by ribosome structure
05/27/2010US20100130504 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2010US20100130493 Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer
05/27/2010US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor
05/27/2010US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
05/27/2010US20100129496 Nutritional formulations
05/27/2010US20100129442 Oral Multi-Functional Pharmaceutical Capsule Preparations Of Proton Pump Inhibitors
05/27/2010US20100129364 Combination therapy for the treatment of ocular neovascular disorders
05/27/2010US20100129339 Nkt cell-stimulating agent for administration through upper respiratory tract mucous membrane
05/27/2010US20100129337 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
05/27/2010US20100129336 Stabilized bacterial formulation
05/27/2010US20100129322 Tetracycline-sensitive bifidobacteria strains
05/27/2010CA2744031A1 Anticancer combination comprising docetaxel and an antisense oligonucleotide
05/27/2010CA2743967A1 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
05/26/2010EP2189537A1 Detection and treatment of schizophrenia
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189162A1 Methods for the treatment of cellular proliferative disorders
05/26/2010EP2189159A1 Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors
05/26/2010EP2187741A1 Novel forms of cddo methyl ester
05/26/2010EP1685135B1 TETRAHYDRO-FURO[3,4-d]DIOXOLE COMPOUNDS AND COMPOSITIONS AND METHOD FOR INHIBITING PLATELET AGGREGATION
05/26/2010EP1575379B1 Nutritional compositions
05/26/2010EP1572168B1 Anti-infarction molecules
05/26/2010EP1539137B1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
05/26/2010EP1370275B1 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
05/26/2010EP1307225B1 Antagonists of cd30 or cd30l for use in treating auto-immune and chronic inflammatory conditions
05/26/2010EP1294371B2 Medium chain fatty acids applicable as antimicrobial agents
05/26/2010EP1272665B1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
05/26/2010EP1144642B1 Compounds and methods for treatment and diagnosis of chlamydial infection
05/26/2010EP1082875B1 Improved brush block housing for propeller deicing system
05/26/2010CN1943565B Biological degradable nano medicinal capsule with MRI tracer effect and its preparing method
05/26/2010CN1935277B Preparation for the prophylaxis of restenosis
05/26/2010CN1912111B Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen
05/26/2010CN1893934B Use of sphingosine-1-phosphate (s1p) receptor agonists for the treatment of brain degenerative diseases
05/26/2010CN1871010B Prophylaxis and/or treatment of portal hypertension
05/26/2010CN1803189B Use of neurotoxin therapy for treatment of urologic and related disorders
05/26/2010CN1803144B Pharmaceutical composition containing clofibrate compound and B family vitamin
05/26/2010CN1795926B Pharamaceutical use for treating skin conditions
05/26/2010CN1794976B Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals
05/26/2010CN1781545B Method for extracting herbal medicine
05/26/2010CN1753683B Ophthalmic formulation for the prevention and treatment of ocular conditions
05/26/2010CN1671412B Immunostimulatory compositions and methods of stimulating an immune response
05/26/2010CN1671407B Compositions and methods for treating diabetes
05/26/2010CN1665933B Immunoconjugates for the treatment of tumours
05/26/2010CN1665507B Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
05/26/2010CN1662229B Use of taurine or hypotaurine for preparing medicine for the treatment of alopecia
05/26/2010CN1646138B Novel therapeutical use of agonist ligands specific to G2A receptor
05/26/2010CN1635872B Proliposomal drug delivery system
05/26/2010CN1553814B Remedies for arteriosclerosis
05/26/2010CN1518458B Graft rejection inhibitors
05/26/2010CN1468308B Anti-TNF antibodies, compositions, methods and uses
05/26/2010CN1425066B Novel stra6 polypeptides
05/26/2010CN101715349A therapeutic compositions and methods for treating gram-negative bacterial infections
05/26/2010CN101715345A Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha
05/26/2010CN101712721A T cell receptor fusions and conjugates and methods of use thereof
05/26/2010CN101711869A Application of quinolones anti-bacterial medicines to curing psoriasis
05/26/2010CN101711868A Gene detection assay for improving the likelihood of an effective response to a ErbB antibody cancer therapy
05/26/2010CN101711862A Medicine target spot relevant to inflammatory diseases and application thereof
05/26/2010CN101711755A Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
05/26/2010CN101711747A Medicine application preparation for treating hypertension
05/26/2010CN101711737A Agents for intravitreal administration to treat or prevent disorders of the eye
05/26/2010CN101152163B Anti-cicatrix externally used pad pasting containing hormone medicament and method for preparing the same
05/26/2010CN101066458B Application of cell nucleus targeting administration system capable of reversing tumor cell resistance
05/26/2010CA2645749A1 Soy kefir powder and uses thereof
05/25/2010US7723505 EAAT2 promoter and uses thereof
05/25/2010US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines
05/25/2010US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins
05/25/2010US7723496 Tumor antigen for diagnosis and treatment of cell proliferative disorders
05/25/2010US7723379 Dosage form of polysaccharides, especially cocoa extracts, containing procyanidine units an additional nitric oxide modulating agent; dietary supplements; pet foods
05/25/2010US7723357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus